Collagen breakdown in ankylosing spondylitis - Relationship to disease related parameters;Kollagenabbauaktivität bei Spondylitis ankylosans in Beziehung zu krankheitsrelevanten Daten

Zeitschrift fur Rheumatologie

Volumn 62, Issue 5, 2003, Pages 459-467

  Bolzner C ^b   Muller A ^b   Braunig E ^a   Hein, G ^a  

^a Klinik fur Innere Medizin IV   (Germany)

^b Rheumatologisches Forschungslabor   (Germany)

Author keywords

Ankylosing spondylitis; Bone metabolism; Collagen crosslinks; Inflammation; Osteoporosis

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN; DEOXYPYRIDINOLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINOLINE;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CATABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DISEASE ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMINO ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BONE DENSITY; C-REACTIVE PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYRIDINIUM COMPOUNDS; REFERENCE VALUES; SEX FACTORS; SPINE; SPONDYLITIS, ANKYLOSING;

EID: 0242351934     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-003-0490-2     Document Type: Article

References (30)

1. Astbury C, Bird HA, Mc Laren AM et al (1994) Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 33:11-15
2. Bronson WD, Walker SE, Hillmann LS et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25:929-935
3. Cantatore FP, Acquista CA, Pipitone V (1999) Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis. J Rheumatol 26:2318-2323
4. Christenson RH (1997) Biochemical markers of bone metabolism. Clin Biochem 30:573-593
5. Cooper C, Carbone L, Michel CJ et al (1994) Fracture risk in patients with ankylosing spondylitis:a population based study. J Rheumatol 21:177-182
6. Devogelaer JP, Maldague B, Malghem J et al (1992) Appendicular and vertebral bone mass in ankylosing spondylitis. Arthr Rheum 35
7. Dougados M, Behier J, Jolchine I et al (2001) Celecoxib, a cox-2 specific inhibitor in ankylosing spondylitis: a 6 week efficacy study. Arthr Rheum 44:180-185
8. Dougados M, Gueguen A, Nakache JP et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26:971-974
9. El Maghraoui A, Borderie D, Cherruau B et al (1999) Osteoporosis, body composision and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205-2209
10. Hanson CA, Shagrin JW, Duncan H (1971) Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop 74:59-64
11. Hein G, Franke S, Müller A, Braunig E, Eidner T, Stein G (1997) The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 16:167-172
12. Kein G, Müller A, Franke S et al (1995) Untersuchungen zur Korrelation der Pyridinium Crosslinks bei der Rheumatoiden Arthritis. Akt Rheumatol 20:140-144
13. Lane N, Coble T, Kimmel DB (1990) Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res 5:1029
14. Lange U, Jung O, Teichmann J et al (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporosis Int 12:1031-1035
15. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-α, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
16. MacDonald AG, Birkinshaw G, Durham B et al (1997) Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 36:50-53
17. Marhoffer W, Stracke H, Masoud I et al (1995) Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 54:556-559
18. McLaren AM, Hordon LD, Bird HA et al (1992) Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effect of bone fracture. Ann Rheum Dis 51:648-651
19. Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364-368
20. Mitra D, Elvins DM, Collins AJ (1999) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fracture. J Rheumatol 26:2201-2204
21. Morton DJ, Barrett-Connor EL, Schneider DL (1998) Nonsteroidal anti-inflammatory drugs and bone mineral density in older women. J Bone Miner Res 13:1924-1931
22. Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridinium crosslinks of collagen. Trends Endocrinol Metab 3:263-270
23. Sivri A, Kilinc S, Kutsal Y (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15:51-54
24. Speden DJ, Calin AI, Ring FJ et al (2002) Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 29:516-521
25. Szejnfeld VL, Monier- Faugere MC, Bogner BJ et al (1997) Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis. J Rheumatol 24:683-688
26. Takahashi M, Suzuki M, Naitou K et al (1999) Comparison of free and peptid-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. Rheumatology 38:133-138
27. Toussirot E, Nguyen NU, Dumoulin G et al (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol 37:1172-1176
28. Toussirot E, Ricard-Blum S, Dumoulin G et al (1999) Relationship between urinary pyridinium crosslink, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 38:21-27
29. Will R, Palmer R, Ring F et al (1989) Osteoporosis in early ankylosing spondylitis. Lancet 2:1483-1485
30. Xuereb Anastasi A, Buhagiar A, Camilleri F et al (1999) Pyridinium crosslinks excretion in patients with rheumatoid arthritis. Correlation with disease activity and glucocorticoid treatment. Adv Exp Med Biol 455:227-233